CardioComm Solutions, Inc.
CardioComm Solutions, Inc. (EKGGF) Revenue
Annual & quarterly revenue history · segment & region breakdown
EKGGF · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsCardioComm Solutions, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 48.37% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -48.37% |
| 2024-12-31 | $0.00B | -$0.00B | -39.91% |
| 2023-12-31 | $0.00B | -$0.00B | -11.99% |
| 2022-12-31 | $0.00B | +$0.00B | +45.90% |
| 2021-12-31 | $0.00B | -$0.00B | -18.24% |
| 2020-12-31 | $0.00B | -$0.00B | -4.58% |
| 2019-12-31 | $0.00B | -$0.00B | -18.66% |
| 2018-12-31 | $0.00B | -$0.00B | -38.20% |
| 2017-12-31 | $0.00B | +$0.00B | +11.73% |
| 2016-12-31 | $0.00B | -$0.00B | -9.73% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CardioComm Solutions, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CardioComm Solutions, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from CardioComm Solutions, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
EKGGF revenue · 4 questionsEKGGF's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 48.37% year-over-year from $0.00B in FY2025.
▸ Source: FMP · CardioComm Solutions, Inc. SEC filings · GAAP · CardioComm Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026